Literature DB >> 28382624

Cinacalcet as an alternative to phosphate therapy in X-linked hypophosphataemic rickets.

Uri S Alon1, Dale Jarka2, Penny J Monachino1, Judith Sebestyen VanSickle1, Tarak Srivastava1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28382624     DOI： 10.1111/cen.13346

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN： 0300-0664            Impact factor:   3.478


× No keyword cloud information.
  8 in total

Review 1.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

Review 2.  Use of calcimimetics in children with normal kidney function.

Authors:  Judith Sebestyen VanSickle; Tarak Srivastava; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2018-03-19       Impact factor: 3.714

Review 3.  Developments in rare bone diseases and mineral disorders.

Authors:  Siobhan Bacon; Rachel Crowley
Journal:  Ther Adv Chronic Dis       Date:  2017-11-24       Impact factor: 5.091

Review 4.  Pharmacological management of X-linked hypophosphataemia.

Authors:  Erik A Imel; Kenneth E White
Journal:  Br J Clin Pharmacol       Date:  2018-10-29       Impact factor: 4.335

Review 5.  FGF23, Hypophosphatemia, and Emerging Treatments.

Authors:  Erik A Imel; Andrew Biggin; Aaron Schindeler; Craig F Munns
Journal:  JBMR Plus       Date:  2019-05-13

6.  Off-label use of cinacalcet in pediatric primary hyperparathyroidism: A French multicenter experience.

Authors:  Julie Bernardor; Sacha Flammier; Jean-Pierre Salles; Cyril Amouroux; Mireille Castanet; Anne Lienhardt; Laetitia Martinerie; Ivan Damgov; Agnès Linglart; Justine Bacchetta
Journal:  Front Pediatr       Date:  2022-08-24       Impact factor: 3.569

Review 7.  The Molecular Basis of Calcium and Phosphorus Inherited Metabolic Disorders.

Authors:  Anna Papadopoulou; Evangelia Bountouvi; Fotini-Eleni Karachaliou
Journal:  Genes (Basel)       Date:  2021-05-13       Impact factor: 4.096

Review 8.  Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review.

Authors:  S Giannini; M L Bianchi; D Rendina; P Massoletti; D Lazzerini; M L Brandi
Journal:  Osteoporos Int       Date:  2021-05-19       Impact factor: 4.507
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.